Evolution of the Average Target: Synopsys, Inc.

Evolution of the Target Price: Synopsys, Inc.

Changes in Analyst Recommendations: Synopsys, Inc.

d46d9707f309379f8729.E5Ri9ZN5fy8Gl3auB9gLrO5deFqiOWlFvz2Mum4pwQ4.XcA9v6MAGFox0QzJModM57ocMBjOfwQg0XPj5RZhl0F4zRal_R0ZWWPvEQ~c622cafc9b4156307d53e7584e712d6f
05-14 Wells Fargo Adjusts Price Target on Synopsys to $505 From $450, Maintains Equalweight Rating MT
05-13 Citigroup Adjusts Price Target on Synopsys to $600 From $580, Maintains Buy Rating MT
04-17 Baird Adjusts Synopsys Price Target to $499 From $555, Maintains Neutral Rating MT
02-27 Synopsys' Growth Outlook Softens as Core Business Slows, Morgan Stanley Says MT
02-27 Rothschild & Co Redburn Adjusts Price Target on Synopsys to $540 From $590, Maintains Buy Rating MT
02-27 Morgan Stanley Downgrades Synopsys to Equalweight From Overweight, Adjusts PT to $480 From $550 MT
02-27 Analyst recommendations: CoreWeave, Duolingo, Palantir, Intuit, Paramount… Zonebourse
02-26 Griffin Securities Lowers Synopsys Price Target to $538 From $560 MT
02-26 Synopsys is Fundamentally Immune to AI Disruption Fears, BofA Says MT
02-26 Synopsys is Fundamentally Immune to AI Disruption Fears, BofA Says MT
02-26 BofA Securities Adjusts Synopsys Price Target to $515 From $560, Maintains Buy Rating MT
02-26 HSBC Adjusts Synopsys PT to $460 From $455, Maintains Hold Rating MT
02-26 Piper Sandler Adjusts Synopsys PT to $430 From $520, Maintains Neutral Rating MT
02-26 Wolfe Research Adjusts Synopsys PT to $530 From $540, Maintains Outperform Rating MT
02-26 Wells Fargo Adjusts Synopsys PT to $450 From $500, Maintains Equal Weight Rating MT
02-26 Rosenblatt Securities Adjusts Synopsys PT to $530 From $560, Maintains Buy Rating MT
02-20 HSBC Downgrades Synopsys to Hold From Buy, Adjusts Price Target to $455 From $545 MT
01-20 Rothschild & Co Redburn Adjusts Price Target on Synopsys to $590 From $550, Maintains Buy Rating MT
01-13 Synopsys Shares Fall After Piper Sandler Downgrade MT
01-13 Analyst recommendations: Albemarle, Five Below, Live Nation, Mastercard, Moody's…. Zonebourse
01-13 Piper Sandler Downgrades Synopsys to Neutral From Overweight, Adjusts PT to $520 From $602 MT
01-02 Loop Capital Adjusts Price Target on Synopsys to $600 From $570, Maintains Buy Rating MT
12-12 Berenberg Raises Price Target on Synopsys to $540 From $500, Keeps Buy Rating MT
12-11 BofA Upgrades Synopsys to Buy From Neutral, Adjusts Price Target to $560 From $500 MT
12-11 Morgan Stanley Adjusts Price Target on Synopsys to $550 From $510, Maintains Overweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+8.84%
+34.31%
+35.83%
-7.43%
+12.25%
+3.66%
+60.97%
+16.34%
+45.99%
+13.26%
Average +22.40%
Weighted average by Cap. +31.53%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
498.93USD
Average target price
537.53USD
Spread / Average Target
+7.74%
High Price Target
650.00USD
Spread / Highest target
+30.28%
Low Price Target
403.85USD
Spread / Lowest Target
-19.06%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Wells Fargo Securities
Citigroup
Baird
Rothschild & Co Redburn
Morgan Stanley
Griffin Securities
BofA Securities
HSBC
Piper Sandler
Wolfe Research
Rosenblatt Securities
Loop Capital
Berenberg Bank
Needham & Co.
JPMorgan Chase
KeyBanc Capital Markets
Goldman Sachs
BNP Paribas Exane
Citic Securities
Deutsche Bank Securities
Mizuho Securities
Stifel Nicolaus
Redburn Atlantic
Morningstar
Edward Jones
UBS
Atlantic Equities
DA Davidson
Credit Suisse
WestPark Capital
J.P. Morgan Chase
RBC Capital Markets
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
498.93USD
Average target price
537.53USD
Spread / Average Target
+7.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SNPS Stock
  4. Consensus Synopsys, Inc.